source
- Biotech firms rally to defend FDA's mifepristone approval in Louisiana lawsuitBiotech companies, executives and investors filed an amicus brief supporting the FDA in the Louisiana case that seeks to limit access to the abortion pill mifepristone. The brief is signed by 61 e…
- FDA to appoint permanent heads of CBER and CDER alongside new commissionerThe FDA is preparing to announce a series of senior leadership changes concurrent with the appointment of a new commissioner. Among the planned announcements are permanent appointments for the hea…